A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors
Titel:
A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors
Auteur:
Hudis, Clifford Swanton, Charles Janjigian, Yelena Y Lee, Ray Sutherland, Stephanie Lehman, Robert Chandarlapaty, Sarat Hamilton, Nicola Gajria, Devika Knowles, James Shah, Jigna Shannon, Keith Tetteh, Ernestina Sullivan, Daniel M Moreno, Carolina Yan, Li Han, Hyo Sook